Drug major Dr Reddy's Laboratories today said the US health regulator has completed audit of its API Cuernavaca Plant in Mexico.
"The audit of our API Cuernavaca plant in Mexico by the USFDA has been completed with zero observations," Dr Reddy's Laboratories (DRL) said in a BSE filing.
The stock was trading 0.96 per cent lower at Rs 447 on the BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
